PTK2 and intrahepatic cholangiocarcinoma: Kinase FAK phosphorylates Yap at tyrosine 357, resulting in its activation, and ablation or inhibition of FAK synergized with pallbociclib in inhibiting mouse intrahepatic cholangiocarcinoma [78].